The fabrication of integrated circuits includes many diverse processing steps. One of the operations frequently employed is the deposition of a dielectric film into a gap between features patterned over or into silicon substrates. One of the goals in depositing such material is to form a void-free, seam-free fill in the gap. As device dimensions become smaller in the context of DRAM, flash memory and logic, for example, it has become increasingly difficult to achieve this type of ideal fill.
While deposition methods such as high density plasma (HDP), sub-atmospheric chemical vapor deposition (SACVD), and low pressure chemical vapor deposition (LPCVD) have been used for gap fill, these methods do not achieve the desired fill capability. Flowable chemical vapor deposition and spin-on dielectric (SOD) methods can achieve the desired fill, but tend to deposit highly porous films. Further, these methods are especially complex and costly to integrate, as they require many extra processing steps. Atomic layer deposition (ALD) processes have also been used for gap fill, but these processes suffer from long processing times and low throughput, especially for large gaps. In some cases, multi-step deposition processes are used, including deposition-etch-deposition processes which require distinct etching operations between subsequent deposition operations. The etching may be done to remedy or prevent void formation in the gap. While this method is useful, it would be preferable to use a process that involves only deposition, with no required etch operations.
A further challenge is simultaneously filling gaps of different sizes on a substrate. For example, a deposition method optimized for a wide gap with a small aspect ratio may not be suitable for filling a narrow gap with a large aspect ratio, and vice versa. Therefore, a method of achieving void-free, seam-free fill of dielectric material into a gap is needed, particularly one that may be used to simultaneously fill gaps of various sizes.
Certain embodiments herein relate to methods and apparatus for filling a gap on a semiconductor substrate. In certain cases, the gap is filled through a plasma enhanced atomic layer deposition (PEALD) operation. In other cases, the gap is filled through a hybrid method including both PEALD and plasma enhanced chemical vapor deposition (PECVD) operations. In one aspect of the embodiments herein, a method is provided for filling a gap including (a) introducing a first reactant in vapor phase into a reaction chamber having the substrate therein, and allowing the first reactant to adsorb onto the substrate surface; (b) introducing a second reactant in vapor phase into the reaction chamber and allowing the second reactant to adsorb onto the substrate surface; (c) exposing the substrate surface to plasma to drive a surface reaction between the first and second reactants on the substrate surface to form a film layer that lines the bottom and sidewalls of the gap; (d) sweeping the reaction chamber without performing a pumpdown; and (e) repeating operations (a) through (d) to form additional film layers, where when opposing film layers on opposite sidewalls of the gap approach one another, surface groups present on the opposing film layers crosslink with one another to thereby fill the gap. The methods may be used to fill the gap without the formation of a void or seam.
In some embodiments, the first reactant is a silicon-containing reactant and the second reactant is an oxidizing reactant. For example, the first reactant may include bis(tertiary-butyl-amino)silane (BTBAS). In a further example, the second reactant may include oxygen and/or nitrous oxide. In various cases, the gap is reentrant. Further, in many embodiments, the gap is filled through a mechanism that may be characterized at least in part as a bottom-up fill mechanism. This bottom-up fill mechanism may achieve a seam-free, void-free fill, even where a gap is reentrant.
In another aspect of the disclosed embodiments, a method of filling a gap on a substrate surface is provided, including (a) introducing a first reactant in vapor phase into a reaction chamber having the substrate therein, and allowing the first reactant to adsorb onto the substrate surface; (b) introducing a second reactant in vapor phase into the reaction chamber and allowing the second reactant to adsorb onto the substrate surface; and (c) exposing the substrate surface to plasma to drive a surface reaction between the first and second reactants on the substrate surface to form a film layer that lines the bottom and sidewalls of the gap, where the film is denser and/or thinner near the field region and upper sidewalls of the gap compared to near the bottom and lower sidewalls of the gap. The method may include an operation of (d) sweeping the reaction chamber without performing a pumpdown after (c) is performed. In some embodiments, the method includes repeating operations (a) through (c) (or (a) through (d)) to form additional film layers to thereby fill the gap. In certain embodiments the gap may be filled through a bottom-up fill mechanism, without the formation of a void or seam.
In another aspect of the disclosed embodiments, a method of filling a gap on a substrate surface is provided, including (a) introducing a first reactant in vapor phase into a reaction chamber having the substrate therein, and allowing the first reactant to adsorb onto the substrate surface; (b) introducing a second reactant in vapor phase into the reaction chamber and allowing the second reactant to adsorb onto the substrate surface; (c) exposing the substrate surface to plasma to drive a surface reaction between the first and second reactants on the substrate surface to form a film layer that lines the bottom and sidewalls of the gap, (d) sweeping the reaction chamber without performing a pumpdown; and repeating operations (a) through (d) to form additional film layers where ligands of one or more reactants are preferentially buried in the film near the bottom and lower sidewalls of the gap compared to the field region and upper sidewalls of the gap. The method may include an operation of (d) sweeping the reaction chamber without performing a pumpdown after (c) is performed. In certain embodiments, the gap may be filled through a bottom-up fill mechanism without the formation of a void or seam.
In a further aspect of the disclosed embodiments, a method of filling a gap on a substrate surface is provided, including (a) introducing a first reactant in vapor phase into a reaction chamber having the substrate therein, and allowing the first reactant to adsorb onto the substrate surface; (b) introducing a second reactant in vapor phase into the reaction chamber and allowing the second reactant to adsorb onto the substrate surface; (c) exposing the substrate surface to plasma to drive a surface reaction between the first and second reactants on the substrate surface to form a film lining the gap; (d) sweeping or purging the reaction chamber; (e) introducing a third reactant in vapor phase and fourth reactant in vapor phase into the reaction chamber concurrently; and (f) generating a plasma from the vapor phase reactants to drive a gas phase reaction between the third and fourth reactants, where the gas phase reaction produces a gap-filling material, and where the gap-filling material partially or completely fills the gap on the substrate surface.
The first and second reactants may be the same as at least one of the third and fourth reactants. For example, the first and second reactants may each be the same as the third and fourth reactants. In other cases, there may be no overlap between the first and second reactants and the third and fourth reactants. In many cases, the film formed in (c) is the same material as the gap-filling material formed in (f). For example, the film formed in (c) and the gap-filling material formed in (f) may be silicon oxide. In these cases, the first reactant may be a silicon-containing reactant and the second reactant may be an oxidizing reactant. For example, the first reactant may include BTBAS. In a further example, the second reactant may include oxygen and/or nitrous oxide. In these or other cases, examples of the third reactant may be TEOS or silane, with examples of the fourth reactant being an oxidizing reactant.
In some implementations, operations (a) through (c) are repeated before operations (e) through (f), and no pumpdown occurs after each iteration of operation (c). In these or other cases, the method may be performed without any intervening etching operations. One advantage of the disclosed embodiments is that the method may be performed in a single reaction chamber. In many cases, the substrate is not removed from the reaction chamber during or between any of operations (a) through (f). In some implementations, operations (a) through (c) include forming a conformal film that is thicker at the bottom of the gap than on the upper sidewalls of the gap. This may be achieved in a variety of ways. In some embodiments, operation (c) may include preferentially densifying the film near the top of the gap compared to the film near the bottom of the gap. In these or other embodiments, operation (c) may include preferentially burying ligands of one or more reactants in the film near the bottom of the gap compared to near the upper sidewalls of the gap. Operation (c) may also include promoting crosslinking between the film formed on a first sidewall of the gap and the film formed on an opposing sidewall of the gap.
In yet another aspect of the disclosed embodiments, a method of filling gaps on a substrate surface is provided, including (a) introducing a first reactant in vapor phase into a reaction chamber having the substrate therein, and allowing the first reactant to adsorb onto the substrate surface, where the substrate has at least a narrow gap having a critical dimension less than about 50 nm and a wide gap having a critical dimension greater than or equal to about 50 nm; (b) introducing a second reactant in vapor phase into the reaction chamber and allowing the second reactant to adsorb onto the substrate surface; (c) exposing the substrate surface to plasma to drive a surface reaction between the first and second reactants on the substrate surface to form a film, where the film completely fills the narrow gap and lines the wide gap; (d) sweeping or purging the reaction chamber; (e) introducing a third reactant in vapor phase and fourth reactant in vapor phase into the reaction chamber concurrently; and (f) generating a plasma from the vapor phase reactants to drive a gas phase reaction between the third and fourth reactants, where the gas phase reaction produces a gap-filling material, and wherein the gap-filling material partially or completely fills the wide gap on the substrate surface.
In some cases, the narrow gap has an aspect ratio of greater than about 4:1 and the wide gap has an aspect ratio of less than or equal to about 4:1. The narrow gap may be reentrant in some embodiments. Even where the narrow gap is reentrant, it may be filled without forming seams or voids. In some implementations, operations (a) through (c) are repeated before operations (e) through (f), and no pumpdown occurs after each iteration of operation (c). In these or other cases, the film formed in (c) may be the same material as the gap-filling material formed in (f). In many embodiments, the method is performed without any intervening etching operations. The disclosed embodiments allow the narrow gap and wide gap to be filled without forming seams or voids.
In a further aspect of the disclosed embodiments, an apparatus for filling gaps on a semiconductor substrate is disclosed. The apparatus may include a reaction chamber, a substrate supporter, a plasma generation source, one or more process gas inlets, one or more outlets, and a controller. The controller may be configured to perform any of the methods disclosed herein.
Another aspect of the disclosed embodiments is a method of filling one or more gaps on a semiconductor substrate with a dielectric material, including: (a) depositing a silicon-containing film in the one or more gaps on the substrate through a plasma enhanced atomic layer deposition surface reaction to partially fill the one or more gaps with the silicon-containing film; and (b) depositing additional silicon-containing film on the film deposited in (a) through a plasma enhanced chemical vapor deposition gas-phase reaction to complete fill of the one or more gaps with the silicon-containing film.
These and other features will be described below with reference to the associated drawings.
In this application, the terms “semiconductor wafer,” “wafer,” “substrate,” “wafer substrate,” and “partially fabricated integrated circuit” are used interchangeably. One of ordinary skill in the art would understand that the term “partially fabricated integrated circuit” can refer to a silicon wafer during any of many stages of integrated circuit fabrication thereon. A wafer or substrate used in the semiconductor device industry may have a diameter of 200 mm, or 300 mm, or 450 mm. The following detailed description assumes the invention is implemented on a wafer. However, the invention is not so limited. The work piece may be of various shapes, sizes, and materials. In addition to semiconductor wafers, other work pieces that may take advantage of this invention include various articles such as printed circuit boards, glass panels, and the like.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the presented embodiments. The disclosed embodiments may be practiced without some or all of these specific details. In other instances, well-known process operations have not been described in detail to not unnecessarily obscure the disclosed embodiments. While the disclosed embodiments will be described in conjunction with the specific embodiments, it will be understood that it is not intended to limit the disclosed embodiments.
Conventional gap fill techniques have been unsuccessful in achieving void-free, seam-free fill for high density films in high aspect ratio gaps. HDP, SACVD and LPCVD have only limited fill capability, and typically result in the formation of voids and seams. These voids and seams can open up after a chemical mechanical polishing (CMP) operation, or after an etch-back is performed. These opened seams and voids can then trap materials, such as polysilicon and tungsten, that are subsequently deposited. These materials are often incompletely removed in subsequent CMP or etch-back operations, and can remain in the device to cause shorts and/or loss of yield. Flowable CVD (e.g., flowable oxide) and SOD techniques have complex integration schemes that may result in high costs associated with the various additional steps involved.
Certain embodiments herein relate to a hybrid method of filling differently sized gaps on a semiconductor substrate. The first portion of the method relates to an ALD operation, for example a plasma enhanced ALD (PEALD) operation. The ALD operation may be performed in a novel way to promote a bottom-up type fill in narrow gaps. This bottom-up fill mechanism helps achieve the void-free, seam-free fill, particularly in narrow gaps (e.g., gaps having a critical dimension (CD) of about 50 nm or less) and/or gaps having high aspect ratios (e.g., depth to width aspect ratio of about 4:1 or higher). The ALD operation also acts to form a layer on, but not completely fill, wider gaps present on the substrate (e.g., gaps having a CD larger than about 50 nm) having lower aspect ratios (e.g., aspect ratios of about 4:1 or lower).
The second portion of the method relates to a plasma enhanced chemical vapor deposition (PECVD) method that is used to fill the remainder of the wider gaps. In certain embodiments, this method may be performed using a direct (in situ) capacitively coupled plasma. In many embodiments, a radio frequency (RF) plasma source is employed, though any type of plasma source capable of generating a direct plasma may be employed, including microwave and DC sources. Further, in some embodiments, a remotely-generated plasma may be employed. The remote plasma may be capacitively-coupled or inductively-coupled according to various embodiments.
The plasmas used in the PECVD methods described herein may have lower plasma density than high density plasmas generated by in-situ inductively coupled plasma generators such as those used in HDP processes. For example, in HDP processes plasma densities may be on the order of about 1011-1013 ions/cm3, as opposed to about 108-1010 ions/cm3 for PECVD processes in certain embodiments. HDP methods generally do not produce the required fill results, as described above, and typically require the use of etch operations between subsequent deposition steps. In HDP methods, charged dielectric precursor species are directed downwards to fill the gap. This results in some sputtering of material, which can then redeposit on the sidewalls of the gap, especially near the top of the gap, as well as in the field region. Further, uncharged particles present in the chamber may deposit in the upper sidewall region, as well. This unwanted deposition can build up to form sidewall deposits and top-hats, which prevent the gap from being uniformly filled. Etch steps may be used to combat the undesired upper sidewall deposition that occurs with HDP, though this increases the complexity of the deposition method. If no etch steps are performed, the gap will generally not be able to fill without formation of a void. The HDP methods are also much more expensive to implement, with a lower throughput than PECVD methods.
According to various embodiments, the PEALD and PECVD methods may be implemented in the same chamber. Both of these types of processes run in similar pressure and flow regimes, and can use the same RF power sources. Further, the PECVD methods may be performed in a single step, meaning that no intervening etching operations (or other processes such as deposition processes) are required. By contrast, it is not practical to run PEALD and HDP processes in the same chamber. First, the two processes operate in substantially different pressure regimes. PEALD processes generally run in the range of a few Torr, and benefit from high gas flows for purging. HDP processes operate in the mTorr range, which requires relatively low gas flows compared to what is used with PEALD. Next, HDP processes are typically practiced in large volume chambers, while ALD processes benefit from substantially smaller volumes. Furthermore, HDP processes generally require a different power source than PEALD, which would further complicate reactor design.
Although HDP processes have shown good gap fill, HDP processes suffer from engineering problems related to “forbidden gap” sizes. Where a hybrid ALD/HDP deposition approach is used, a forbidden gap may exist where the CD of the gap is slightly larger than 2× the thickness of the ALD layer deposited. In these cases, the HDP processes are unable to fill the remaining gap. The PECVD methods described herein can fill gaps including those previously lined with PEALD. After any challenging structures are lined/filled with PEALD, the PECVD process may be used to fill remaining structures in a less conformal manner.
The PECVD operation is advantageous in achieving a high deposition rate to fill larger gaps that would take a long time to fill through ALD alone. In some embodiments, however, the methods include only the first operation of performing PEALD.
In various embodiments, the PEALD and PECVD operations are performed in the same chamber. This setup is beneficial, as there is no need to transfer the substrate from a PEALD reaction chamber to a PECVD reaction chamber. Thus, there is no need to worry about moisture getting on or into the film, and there is no corresponding need to perform a de-gassing operation or high temperature anneal to remove the moisture before performing the PECVD operation. Another benefit to the single chamber approach is that it reduces capital costs, cycle times and process flow complexity.
Variations may be made to the basic method described above to achieve different hybrid filling scenarios. In one example, a first portion of the method includes a PEALD operation performed under optimum conditions for filling a high aspect ratio gap, and a second portion of the method includes a more relaxed PEALD operation such as one having reduced dose and purge times. These relaxed PEALD operations may also promote PECVD or partial PECVD deposition. In another example, an etch step is used to taper the gap profile. The etch step may be performed between a first portion of the method and a second portion of the method (e.g., between a PEALD operation and a PECVD operation), or within a single portion of the method (e.g., between two PEALD operations or between two PECVD operations). Of course, the methods may be combined as appropriate. The optimum solution will depend on the actual distribution of aspect ratios and gap dimensions present on the substrate.
Combined PEALD and PECVD methods for filling gaps on substrates are discussed in U.S. patent application Ser. No. 13/084,399, which was incorporated by reference above. In certain cases, as discussed in Ser. No. 13/084,399, there may be a transition phase between an PEALD operation and a PECVD operation in which both PEALD surface reactions and PECVD gas phase reactions occur simultaneously.
In such embodiments, the completed film is generated in part by ALD/CFD and in part by a CVD process such as PECVD. Typically, the ALD/CFD portion of the deposition process is performed first and the PECVD portion is performed second, although this need not be the case. Mixed ALD/CFD with CVD processes can improve the step coverage over that seen with CVD alone and additionally improve the deposition rate over that seen with ALD/CFD alone. In some cases, plasma or other activation is applied while one ALD/CFD reactant is flowing in order to produce parasitic CVD operations and thereby achieve higher deposition rates, a different class of films, etc.
In certain embodiments, two or more ALD/CFD phases may be employed and/or two or more CVD phases may be employed. For example, an initial portion of the film may be deposited by ALD/CFD, followed by an intermediate portion of the film being deposited by CVD, and a final portion of the film deposited by ALD/CFD. In such embodiments, it may be desirable to modify the CVD portion of the film, as by plasma treatment or etching, prior to depositing the later portion of the film by ALD/CFD.
A transition phase may be employed between the ALD/CFD and CVD phases. The conditions employed during such transition phase different from those employed in either the ALD/CFD or the CVD phases. Typically, though not necessarily, the conditions permit simultaneous ALD/CFD surface reactions and CVD type gas phase reactions. The transition phase typically involves exposure to a plasma, which may be pulsed for example. Further, the transition phase may involve delivery of one or more reactants at a low flow rate, i.e., a rate that is significantly lower than that employed in the corresponding ALD/CFD phase of the process.
Methods
Plasma Enhanced Atomic Layer Deposition
The disclosed PEALD processes are useful in achieving void-free, seam-free fill of relatively narrow/high aspect ratio features. Unexpectedly, certain embodiments of the processes appear to result in a bottom-up fill mechanism where material is preferentially deposited near the bottom of the gap as opposed to the top of the gap as the gap is being filled. Although deposition happens on the sidewalls and field region as well, the film deposits thicker at/near the bottom of the gap and in many cases achieves a tapered profile as the gap is filled. The tapered profile is defined to mean that the film deposits thicker near the bottom and thinner near the top of the gap, as shown in the Experimental section, below. This tapered profile is especially useful in achieving a high quality fill without voids or seams in high aspect ratio features. This fill mechanism was unexpected, as atomic layer deposition methods typically result in the formation of a seam as the sidewalls close in towards one another. By promoting bottom-up fill, this seam can be avoided and a more robust device results.
Without wishing to be bound by any theory or mechanism of action, it is believed that the bottom-up fill mechanism may be caused by preferential film densification near the top of the gap. As the film is exposed to plasma, species present in the plasma (especially ions) bombard the film surface, thereby compacting and densifying the film. Under appropriate conditions, this densification may happen preferentially near the top of the gap. Due to the shape of the gap, it is much easier for ions to bombard the film in the field region and near the top of the gap, as opposed to near the bottom of the gap, which is much more protected. Thus, the film near the top becomes denser and thinner than the material near the bottom of the trench, which remains thicker and less dense.
Another factor that may promote seam-free, void-free, bottom-up filling is that crosslinking may occur between groups present on opposing sidewalls of the gap. As deposition proceeds and the sidewalls close in towards one another, the terminal groups may crosslink with one another, thus avoiding any seam. In the case of a gap-filling silicon oxide film, for example, surface hydroxyls/silanols on one sidewall may crosslink with surface hydroxyls/silanols on the opposing wall, thereby liberating water and forming a silicon-oxide matrix. These terminal cross-linking groups may preferentially be found on the sidewalls of a gap.
A further factor that may promote seam-free, void-free, bottom-up filling is that ligand byproducts may be liberated from the film in a non-uniform manner, such that the byproducts become preferentially trapped at or near the bottom of the gap as opposed to near the top of the gap. This entrapment may lead to a higher deposition rate within the feature, especially near the bottom of the gap. For example, where bis(tertiary-butyl-amino)silane (BTBAS) is used as a precursor, one type of ligand byproduct that may become entrapped is tert-butylamine (TBA). It is understood, however, that where ligands become trapped in a growing film, the properties of the film may be affected to some degree.
At operation 105, the second reactant is provided to the reaction chamber. In certain cases, the second reactant is an oxidizing reactant. The second reactant may also be a mix of reactants. In a particular embodiment, the second reactant is a roughly equal volume flow of oxygen and nitrous oxide. As used herein, the phrase “roughly equal volume flow” means that the flow of a first species and the flow of a second species do not differ by more than about 20%, as measured in SLM. The second reactant is provided in operation 105, which may include pre-flowing the reactant before flowing the reactant coincident with plasma activation in operation 107. When the plasma is activated, it drives a reaction between the first and second reactants on the surface of the substrate. Next, the plasma is extinguished, and then the reaction chamber is purged, for example with inert gas or a nitrogen carrier gas. This operation 109 is referred to as the post-RF purge.
The method 100 is typically repeated a number of times to build up the desired film thickness. By using the conditions and methods disclosed herein, the method 100 can result in a fill having a tapered profile and bottom-up fill characteristics. These factors promote void-free, seam-free fill. Advantageously, the film deposited through the disclosed methods are fairly dense.
In a particular example, operation 101 includes providing BTBAS (or other primary reactant) at a flow rate of about 0.5-2.5 mL/min, or about 1.5-2.5 L/min, for example 2 mL/min, for a time period of between about 0.1-1 second, or about 0.2-0.5 seconds, for example about 0.3 seconds. Operation 103 includes purging the reaction chamber with inert gas for between about 0.1-1 seconds, or between about 0.2-0.5 seconds, for example about 0.3 seconds. Operation 105 includes co-flowing O2 and N2O at a flow rate between about 2-20 SLM each, or between about 8-12 SLM each, for example about 10 SLM each. Coincident with this reactant delivery, a plasma is generated at operation 107 using between about 300 W-10 kW, or between about 4-6 kW, for example about 5 kW RF power. These values represent the total RF power delivered, which is divided among four stations/pedestals. The plasma exposure lasts for a duration between about 10 milliseconds and 3 seconds, or between about 0.25-1 second, for example about 0.5 seconds. The RF frequency applied to generate the plasma may be about 13.56 or 27 MHz. Next, the reaction chamber is purged with inert gas at operation 109 for a time period between about 10 milliseconds and 5 seconds, or between about 50-150 milliseconds, for example about 90 milliseconds. It should be understood that the above conditions are examples, with other reactants, flow rates, pulse times, and power used as appropriate for the particular implementation.
The PEALD methods described herein may be conformal film deposition (CFD) methods. Plasma enhanced conformal film deposition techniques and apparatus are further discussed and described in U.S. patent application Ser. No. 13/084,399, filed Apr. 11, 2011, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION,” which is incorporated by reference in its entirety above.
PEALD Reactants
The disclosed methods and apparatus are not limited to use with particular precursors. While the methods have already proven to be effective with certain precursors (as shown in the Experimental section) it is believed that the methods may also be used with a variety of other precursors to gain similar benefits.
At least one of the reactants will generally contain an element that is solid at room temperature, the element being incorporated into the film formed by the PEALD/PECVD method. This reactant may be referred to as a principal reactant. The principal reactant typically includes, for example, a metal (e.g., aluminum, titanium, etc.), a semiconductor (e.g., silicon, germanium, etc.), and/or a non-metal or metalloid (e.g., boron). The other reactant is sometimes referred to as an auxiliary reactant or a co-reactant. Non-limiting examples of co-reactants include oxygen, ozone, hydrogen, hydrazine, water, carbon monoxide, nitrous oxide, ammonia, alkyl amines, and the like. The co-reactant may also be a mix of reactants, as mentioned above.
The PEALD/PECVD process may be used to deposit a wide variety of film types and in particular implementations to fill gaps with these film types. While much of the discussion herein focuses on the formation of undoped silicon oxides, other film types such as nitrides, carbides, oxynitrides, carbon-doped oxides, nitrogen-doped oxides, borides, etc. may also be formed. Oxides include a wide range of materials including undoped silicate glass (USG), doped silicate glass. Examples of doped glasses included boron doped silicate glass (BSG), phosphorus doped silicate glass (PSG), and boron phosphorus doped silicate glass (BPSG). Still further, the PEALD/PECVD process may be used for metal deposition and feature fill.
While the disclosed embodiments are not limited to particular reactants, an exemplary list of reactants is provided below.
In certain embodiments, the deposited film is a silicon-containing film. In these cases, the silicon-containing reactant may be for example, a silane, a halosilane or an aminosilane. A silane contains hydrogen and/or carbon groups, but does not contain a halogen. Examples of silanes are silane (SiH4), disilane (Si2H6), and organo silanes such as methyl silane, ethyl silane, isopropylsilane, t-butylsilane, dimethylsilane, diethyl silane, di-t-butyl silane, allylsilane, sec-butyl silane, thexylsilane, isoamylsilane, t-butyldisilane, di-t-butyldisilane, tetra-ethyl-ortho-silicate (also known as tetra-ethoxy-silane or TEOS) and the like. A halosilane contains at least one halogen group and may or may not contain hydrogens and/or carbon groups. Examples of halosilanes are iodosilanes, bromosilanes, chlorosilanes and fluorosilanes. Although halosilanes, particularly fluorosilanes, may form reactive halide species that can etch silicon materials, in certain embodiments described herein, the silicon-containing reactant is not present when a plasma is struck. Specific chlorosilanes are tetrachlorosilane (SiCl4), trichlorosilane (HSiCl3), dichlorosilane (H2SiCl2), monochlorosilane (ClSiH3), chloroallylsilane, chloromethyl silane, dichloromethyl silane, chlorodimethyl silane, chloroethylsilane, t-butylchlorosilane, di-t-butylchlorosilane, chloroisopropylsilane, chloro-sec-butyl silane, t-butyldimethylchlorosilane, thexyldimethylchlorosilane, and the like. An aminosilane includes at least one nitrogen atom bonded to a silicon atom, but may also contain hydrogens, oxygens, halogens and carbons. Examples of aminosilanes are mono-, di-, tri- and tetra-aminosilane (H3Si(NH2)4, H2Si(NH2)2, HSi(NH2)3 and Si(NH2)4, respectively), as well as substituted mono-, di-, tri- and tetra-aminosilanes, for example, t-butylaminosilane, methylaminosilane, tert-butylsilanamine, bis(tertiarybutylamino)silane (SiH2(NHC(CH3)3)2 (BTBAS), tert-butyl silylcarbamate, SiH(CH3)—(N(CH3)2)2, SiHCl—(N(CH3)2)2, (Si(CH3)2NH)3 and the like. A further example of an aminosilane is trisilylamine (N(SiH3)).
In other cases, the deposited film contains metal. Examples of metal-containing films that may be formed include oxides and nitrides of aluminum, titanium, hafnium, tantalum, tungsten, manganese, magnesium, strontium, etc., as well as elemental metal films. Example precursors may include metal alkylamines, metal alkoxides, metal alkylamides, metal halides, metal β-diketonates, metal carbonyls, organometallics, etc. Appropriate metal-containing precursors will include the metal that is desired to be incorporated into the film. For example, a tantalum-containing layer may be deposited by reacting pentakis(dimethylamido)tantalum with ammonia or another reducing agent. Further examples of metal-containing precursors that may be employed include trimethylaluminum, tetraethoxytitanium, tetrakis-dimethyl-amido titanium, hafnium tetrakis(ethylmethylamide), bis(cyclopentadienyl)manganese, bis(n-propylcyclopentadienyl)magnesium, etc.
In certain implementations, an oxygen-containing oxidizing reactant is used. Examples of oxygen-containing oxidizing reactants include oxygen, ozone, nitrous oxide, carbon monoxide, etc.
In some embodiments, the deposited film contains nitrogen, and a nitrogen-containing reactant is used. A nitrogen-containing reactant contains at least one nitrogen, for example, ammonia, hydrazine, amines (e.g., amines bearing carbon) such as methylamine, dimethylamine, ethylamine, isopropylamine, t-butylamine, di-t-butylamine, cyclopropylamine, sec-butylamine, cyclobutylamine, isoamyl amine, 2-methylbutan-2-amine, trimethylamine, diisopropylamine, diethylisopropylamine, di-t-butylhydrazine, as well as aromatic containing amines such as anilines, pyridines, and benzylamines. Amines may be primary, secondary, tertiary or quaternary (for example, tetraalkylammonium compounds). A nitrogen-containing reactant can contain heteroatoms other than nitrogen, for example, hydroxylamine, t-butyloxycarbonyl amine and N-t-butyl hydroxylamine are nitrogen-containing reactants.
Other precursors, such as will be apparent to or readily discernible by those skilled in the art given the teachings provided herein, may also be used.
Gap Conditions
The disclosed PEALD process is especially useful for filling relatively narrow gaps (CD<about 50 nm) having a relatively high aspect ratio (AR>about 4:1). However, the process may also be performed on larger gaps and gaps having smaller ARs, as well.
In various embodiments, the PEALD process is performed on a substrate having at least two different types of gaps. A first type may include gaps having a CD less than about 50 nm, and/or an AR greater than about 4:1. This first type is referred to as a narrow gap. A second type may include gaps having a CD greater than about 50 nm, and/or an AR less than about 4:1. This second type is referred to as a wide gap. For the reasons discussed above, it can be difficult to simultaneously fill both narrow and wide gaps. Another way to characterize the different types of gaps is by comparing their sizes relative to one another. In some cases, a wide gap is at least about 2 times, or at least about 5 times, or at least about 10 times wider than a narrow gap. In these or other cases, the AR of the narrow gap may be at least about 2 times, or at least about 5 times, or at least about 10 times greater than the AR of the wide gap.
In many implementations where the PEALD process is performed on a substrate having both narrow and wide gaps, the PEALD process will act to completely fill the narrow gap, and line the surface of the wide gap.
This fill mechanism has not been previously observed with PEALD type processes. Instead, conventional PEALD processes form films that have no such tapered profile, where more vertical sidewalls grow towards one another and meet in the center. In these conventional methods, chemicals may get trapped in the extremely narrow void/seam formed in the center of the gap. This trapping is likely to occur, in part because the entire height of the gap closes in at substantially the same time. Conversely, with the disclosed methods, the sidewalls close in towards each other to a greater degree towards the bottom of the gap as opposed to the top of the gap. Thus, as the sidewalls grow towards one another, the bottom of the deposited film grows upwards, and chemicals present in the gap are pushed out. This results in a process where seam and void formation is avoided, producing an excellent quality filled gap.
In some embodiments, a gap filled by a PEALD operation has a reentrant profile. In other words, the gap is smaller at an upper portion and wider at a lower portion. It has been observed that bottom-up fill can be achieved with the disclosed PEALD process, even with gaps that have a somewhat reentrant profile. These results are shown below in the Experimental section.
Chamber Conditions
The PEALD process has been shown to be fairly resilient to changes in temperature. In particular, the process has been shown to be effective at 200° C. and 400° C. In some embodiments, therefore, the process is conducted at a temperature between about 200-400° C. In other cases, however, the temperature may fall outside this range.
The pressure inside the reaction chamber during the PEALD process may be between about 1-10 Torr, or between about 3-7 Torr, for example about 6 Torr.
Plasma Generation Conditions
In the PEALD operation, the substrate is exposed to plasma to drive the reaction between the first and second reactants. Various types of plasma may be used to drive this reaction including capacitively coupled plasmas and inductively coupled plasmas. Various types of plasma generators may be used including RF, DC, and microwave plasma generators. Moreover, according to various embodiments, the plasma may be direct or remote.
The gas used to generate the plasma may include an inert gas such as argon or helium. The gas will also typically include one of the reactants, for example an oxidizing reactant where an oxide film is being formed.
In many cases, an RF signal is used to drive plasma formation. In some embodiments, the RF applied is high frequency RF only, for example at a frequency of about 13.56 or 27 MHz. In other embodiments, the RF has a low frequency component as well. The RF power delivered to drive plasma formation may be between about 300 W and about 10 kW. In some cases, the RF power delivered is between about 4-6 kW, for example about 5 kW. These values represent the total power delivered, which is divided among four stations/pedestals.
Additional plasma generation conditions are discussed in U.S. patent application Ser. No. 13/084,399, filed Apr. 11, 2011, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION,” which is incorporated by reference above.
The duration of plasma exposure may vary between different embodiments. In some cases, RF power is applied for between about 10 milliseconds and 3 seconds, or between about 0.25 seconds and about 1 second. In a particular example, RF power is applied for about 0.5 seconds. The RF power and RF time determine the RF flux delivered to the chamber. It has been found that by increasing the RF flux (either by increasing RF time or power), the wet etch rate (WER) of the film may be reduced. Because the PEALD process has shown a fair resilience to different RF conditions, these variables may be used to achieve a tunable WER.
Purge Conditions
Generally, two sweep/purge operations occur during a single cycle of a PEALD reaction. The first purge occurs after the dose of the first reactant is delivered to the processing chamber, and may be referred to as a reactant purge. This purge is conducted to sweep out any remaining, non-adsorbed first reactant. The second purge occurs after the substrate is exposed to plasma, and may be referred to as the post-RF purge. This purge is conducted to sweep out any remaining reactants, as well as any film formation byproducts.
There are various ways to purge a reaction chamber. One method involves supplying the chamber with a flow of non-reactant gas (e.g., argon, helium, nitrogen, etc.) to sweep out any undesired species. With a sweep, the pressure in the reaction chamber stays substantially constant. Another method of purging a reaction chamber is to perform a pump down. Where this is the case, a vacuum is applied and the reaction chamber is evacuated. During the evacuation, the pressure in the reaction chamber is significantly reduced, for example to less than about 1 Torr.
It has been found that gapfill results are better where the post-RF purge includes a sweep, as compared to a pump down. Without wishing to be bound by a particular theory or mechanism of action, it is believed that the post-RF conditions, including the presence or absence of a pump down, may affect the surface functionality present on the surface of the deposited film. This surface functionality may determine whether or not crosslinking occurs between opposing sidewalls as the gap is filled. One way to encourage the desired bottom-up deposition pattern is to sweep the reaction chamber instead of performing a pump down. Thus, in certain embodiments, no pump down is performed after plasma exposure during the PEALD deposition. In some cases, however, a pump down may be performed between a PEALD operation and a PECVD operation.
The reactant purge may be performed for a duration between about 0.1-1 seconds, for example between about 0.2-0.5 seconds. In a particular example, the reactant purge has a duration of about 0.3 seconds.
The post-RF purge may be performed for a duration between about 0.01-5 seconds, for example between about 0.05-0.15 seconds. In one case the post-RF purge has a duration of about 0.09 seconds.
Plasma Enhanced Chemical Vapor Deposition
The PECVD methods disclosed herein may be practiced after a PEALD process to finish filling gaps that were only partially filled/lined. This method is advantageous compared to a PEALD process alone because it offers a much higher deposition rate, resulting in decreased processing times and increased throughput. Thus, the PEALD process may be used to fill small gaps and line large gaps, and then the PECVD process may be used to complete the filling of the large gaps. This offers a convenient way to fill features of varying sizes and aspect ratios. In many cases, the gaps can be filled without any intervening etching operations.
In a PECVD reaction, a substrate is exposed to one or more volatile precursors, which react and/or decompose to produce the desired deposit on the substrate surface.
In one example process, operation 501 includes flowing TEOS at a rate of about 1-20 mL/min and O2 at a rate of about 2,000-30,000 sccm. RF power is applied with an HF component between about 200-3,000 W, and an LF component between about 200-2,500 W (divided among four stations). The HF frequency is about 13.56 or 27 MHz, while the LF frequency is between about 300-400 kHz. The pressure in the reaction chamber is between about 1-10 Torr, and the temperature is between about 100-450° C. Of course, it is understood that in other embodiments, the reactants, chamber conditions, timing, etc. may vary depending on the desired film and application. The values provided in this section are not intended to be limiting.
PECVD methods and apparatus are further discussed and described in the following patent documents, which are each herein incorporated by reference in their entireties: U.S. Pat. No. 7,381,644, titled “PULSED PECVD METHOD FOR MODULATING HYDROGEN CONTENT IN HARD MASK”; U.S. Pat. No. 8,110,493, titled “PULSED PECVD METHOD FOR MODULATING HYDROGEN CONTENT IN HARD MASK”; U.S. Pat. No. 7,923,376, titled “METHODS OF REDUCING DEFECTS IN PECVD TEOS FILMS”; and U.S. patent application Ser. No. 13/478,999, titled “PECVD DEPOSITION OF SMOOTH SILICON FILMS,” filed May 23, 2012.
In many cases, there will be no downtime between a PEALD process and a PECVD process. For example, the PEALD process may end by extinguishing the plasma, performing the post-RF purge (with or without a pump down), and then immediately flowing the PECVD reactant(s).
In some embodiments, hybrid PEALD/PECVD methods as discussed and described in U.S. patent application Ser. No. 13/084,399, filed Apr. 11, 2011, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION,” which is incorporated by reference above, may be used.
PECVD Reactants
The PECVD reaction may be performed with either the same reactants as the ALD reaction, or with different reactants. In one embodiment, the PEALD reaction is performed with BTBAS and a mixture of O2/N2O, and the PECVD reaction is performed with TEOS and/or silane. The TEOS and silane reactants have been found to be especially useful in practicing the PECVD reaction. Generally, the reactants listed above in the PEALD Reactants section may be used in the PECVD reaction.
The flow rate of reactants may vary depending on the desired process. In one embodiment related to PECVD undoped silicate glass (USG), SiH4 is used as a reactant and has a flow rate between about 100-1,500 sccm, with a flow of N2O between about 2,000-20,000 sccm. In another embodiment related to PECVD using TEOS, the flow of TEOS is between about 1-20 mL/min, and the flow of O2 is between about 2,000-30,000 sccm.
Chamber Conditions
The temperature in the reaction chamber during the PECVD reaction may be between about 50-450° C., in certain embodiments. This range may be especially appropriate for reactions using silane. Where other reactants are used, the temperature range may be more limited or more broad, for example between about 100-450° C. where TEOS is used.
The pressure in the reaction chamber during the PECVD reaction may be between about 1-10 Torr, for example about 5 Torr.
Because the chamber conditions are very similar between the PEALD operation and the PECVD operation, it is feasible to implement both types of reactions in a single reaction chamber. As discussed above, this is advantageous because it reduces or eliminates the risk of moisture entering the film as the substrate is moved between processing chambers, and reduces the need to perform a degassing operation between the two processes.
Plasma Generation Conditions
The PECVD reactions are driven by exposure to plasma. The plasma may be a capacitively coupled plasma or a remotely generated inductively coupled plasma. For the reasons discussed above, it may be preferable to avoid using an in situ inductively coupled plasma.
The gas used to generate the plasma will include at least one reactant. The plasma generation gas may also include other species, as well. For example, in certain embodiments the plasma generation gas includes an inert gas.
The frequency used to drive plasma formation may contain both LF and HF components. In some embodiments the HF frequency may be about 13.56 MHz or about 27 MHz. The LF frequency may be between about 300-400 kHz. The HF RF power used to drive plasma formation may be between about 200-3,000 W. The LF RF power used to drive plasma formation may be between about 200-2,500 W. These power levels represent the total power delivered, which is divided among four stations. The duration of plasma exposure depends on the desired thickness of the deposited film.
In some embodiments, pulsed PECVD methods may be used. These methods may involve pulsing precursor and/or RF power levels.
Purge Conditions
A purge is typically conducted after the PECVD deposition is complete. This purge operates to remove reactants and any byproducts from the reaction chamber. Because the film is already deposited at this point, the purge conditions are less important than with the PEALD reactions, which require many iterations of reactant purge and post-RF purge as the PEALD film is formed.
Apparatus
A suitable apparatus for performing the disclosed methods typically includes hardware for accomplishing the process operations and a system controller having instructions for controlling process operations in accordance with the present invention. For example, in some embodiments, the hardware may include one or more PEALD, PECVD or joint PEALD/PECVD process stations included in a process tool.
Within the reactor, a wafer pedestal 618 supports a substrate 616. The pedestal typically includes a chuck, a fork, or lift pins to hold and transfer the substrate during and between the deposition and/or plasma treatment reactions. The chuck may be an electrostatic chuck, a mechanical chuck or various other types of chuck as are available for use in the industry and/or research.
The process gases are introduced via inlet 612. Multiple source gas lines 610 are connected to manifold 608. The gases may be premixed or not. Appropriate valving and mass flow control mechanisms are employed to ensure that the correct gases are delivered during the deposition and plasma treatment phases of the process. In the case that the chemical precursor(s) are delivered in liquid form, liquid flow control mechanisms are employed. The liquid is then vaporized and mixed with other process gases during its transportation in a manifold heated above its vaporization point before reaching the deposition chamber.
Process gases exit chamber 600 via an outlet 622. A vacuum pump 626 (e.g., a one or two stage mechanical dry pump and/or a turbomolecular pump) typically draws process gases out and maintains a suitably low pressure within the reactor by a close loop controlled flow restriction device, such as a throttle valve or a pendulum valve.
The invention may be implemented on a multi-station or single station tool. In specific embodiments, the 300 mm Novellus Vector™ tool having a 4-station deposition scheme or the 200 mm Sequel™ tool having a 6-station deposition scheme are used. It is possible to index the wafers after every deposition and/or post-deposition plasma anneal treatment until all the required depositions and treatments are completed, or multiple depositions and treatments can be conducted at a single station before indexing the wafer. It has been shown that film stress is the same in either case. However, conducting multiple depositions/treatments on one station is substantially faster than indexing following each deposition and/or treatment.
The depicted processing chamber 2414 comprises four process stations, numbered from 1 to 4 in the embodiment shown in
In some embodiments, system controller 2450 controls all of the activities of process tool 2400. System controller 2450 executes system control software 2458 stored in mass storage device 2454, loaded into memory device 2456, and executed on processor 2452. System control software 2458 may include instructions for controlling the timing, mixture of gases, chamber and/or station pressure, chamber and/or station temperature, purge conditions and timing, wafer temperature, RF power levels, RF frequencies, substrate, pedestal, chuck and/or susceptor position, and other parameters of a particular process performed by process tool 2400. System control software 2458 may be configured in any suitable way. For example, various process tool component subroutines or control objects may be written to control operation of the process tool components necessary to carry out various process tool processes in accordance with the disclosed methods. System control software 2458 may be coded in any suitable computer readable programming language.
In some embodiments, system control software 2458 may include input/output control (IOC) sequencing instructions for controlling the various parameters described above. For example, each phase of a PEALD process may include one or more instructions for execution by system controller 2450. The instructions for setting process conditions for a PEALD process phase may be included in a corresponding PEALD recipe phase. In some embodiments, the PEALD recipe phases may be sequentially arranged, so that all instructions for a PEALD process phase are executed concurrently with that process phase. The same can be said for PECVD processes and hybrid PEALD/PECVD processes.
Other computer software and/or programs stored on mass storage device 2454 and/or memory device 2456 associated with system controller 2450 may be employed in some embodiments. Examples of programs or sections of programs for this purpose include a substrate positioning program, a process gas control program, a pressure control program, a heater control program, and a plasma control program.
A substrate positioning program may include program code for process tool components that are used to load the substrate onto pedestal 2418 and to control the spacing between the substrate and other parts of process tool 2400.
A process gas control program may include code for controlling gas composition and flow rates and optionally for flowing gas into one or more process stations prior to deposition in order to stabilize the pressure in the process station. A pressure control program may include code for controlling the pressure in the process station by regulating, for example, a throttle valve in the exhaust system of the process station, a gas flow into the process station, etc.
A heater control program may include code for controlling the current to a heating unit that is used to heat the substrate. Alternatively, the heater control program may control delivery of a heat transfer gas (such as helium) to the substrate.
A plasma control program may include code for setting RF power levels applied to the process electrodes in one or more process stations.
In some embodiments, there may be a user interface associated with system controller 2450. The user interface may include a display screen, graphical software displays of the apparatus and/or process conditions, and user input devices such as pointing devices, keyboards, touch screens, microphones, etc.
In some embodiments, parameters adjusted by system controller 2450 may relate to process conditions. Non-limiting examples include process gas composition and flow rates, temperature, pressure, plasma conditions (such as RF bias power levels), pressure, temperature, etc. These parameters may be provided to the user in the form of a recipe, which may be entered utilizing the user interface.
Signals for monitoring the process may be provided by analog and/or digital input connections of system controller 2450 from various process tool sensors. The signals for controlling the process may be output on the analog and digital output connections of process tool 2400. Non-limiting examples of process tool sensors that may be monitored include mass flow controllers, pressure sensors (such as manometers), thermocouples, etc. Appropriately programmed feedback and control algorithms may be used with data from these sensors to maintain process conditions.
System controller 2450 may provide program instructions for implementing the above-described deposition processes. The program instructions may control a variety of process parameters, such as DC power level, RF power level, RF bias power level, pressure, temperature, etc. The instructions may control the parameters to operate in-situ deposition of film stacks according to various embodiments described herein.
Lithographic patterning of a film typically comprises some or all of the following steps, each step enabled with a number of possible tools: (1) application of photoresist on a workpiece, e.g., a substrate having a silicon nitride film formed thereon, using a spin-on or spray-on tool; (2) curing of photoresist using a hot plate or furnace or other suitable curing tool; (3) exposing the photoresist to visible or UV or x-ray light with a tool such as a wafer stepper; (4) developing the resist so as to selectively remove resist and thereby pattern it using a tool such as a wet bench or a spray developer; (5) transferring the resist pattern into an underlying film or workpiece by using a dry or plasma-assisted etching tool; and (6) removing the resist using a tool such as an RF or microwave plasma resist stripper. In some embodiments, an ashable hard mask layer (such as an amorphous carbon layer) and another suitable hard mask (such as an antireflective layer) may be deposited prior to applying the photoresist.
It is to be understood that the configurations and/or approaches described herein are exemplary in nature, and that these specific embodiments or examples are not to be considered in a limiting sense, because numerous variations are possible. The specific routines or methods described herein may represent one or more of any number of processing strategies. As such, various acts illustrated may be performed in the sequence illustrated, in other sequences, in parallel, or in some cases omitted. Likewise, the order of the above described processes may be changed.
The subject matter of the present disclosure includes all novel and nonobvious combinations and sub-combinations of the various processes, systems and configurations, and other features, functions, acts, and/or properties disclosed herein, as well as any and all equivalents thereof.
It should be noted that the gaps shown in
This application is a continuation of and claims priority to U.S. application Ser. No. 14/137,860, filed Dec. 20, 2013, titled “GAPFILL OF VARIABLE ASPECT RATIO FEATURES WITH A COMPOSITE PEALD AND PECVD METHOD,” which claims the benefit of U.S. Provisional Application No. 61/884,923, filed Sep. 30, 2013, and titled “GAPFILL OF VARIABLE ASPECT RATIO FEATURES WITH A COMPOSITE PEALD AND PECVD METHOD,” both of which are incorporated herein by reference in their entireties and for all purposes. This application is also a continuation-in-part of U.S. patent application Ser. No. 13/084,399, filed Apr. 11, 2011, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION,” which claims benefit of the following prior U.S. Provisional Application Nos. 61/324,710, filed Apr. 15, 2010, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION”; 61/372,367, filed Aug. 10, 2010, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION”; 61/379,081, filed Sep. 1, 2010, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION”; and 61/417,807, filed Nov. 29, 2010, and titled “PLASMA ACTIVATED CONFORMAL FILM DEPOSITION,” all of which are herein incorporated by reference in their entireties and for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4500563 | Ellenberger et al. | Feb 1985 | A |
5223443 | Chinn et al. | Jun 1993 | A |
5230929 | Caporiccio et al. | Jul 1993 | A |
5496608 | Matsuda et al. | Mar 1996 | A |
5593914 | Evans, Jr. et al. | Jan 1997 | A |
5670432 | Tsai | Sep 1997 | A |
5856003 | Chiu | Jan 1999 | A |
5874368 | Laxman et al. | Feb 1999 | A |
5932286 | Beinglass et al. | Aug 1999 | A |
6069058 | Hong | May 2000 | A |
6100202 | Lin et al. | Aug 2000 | A |
6218293 | Kraus et al. | Apr 2001 | B1 |
6270572 | Kim et al. | Aug 2001 | B1 |
6346741 | Van Buskirk et al. | Feb 2002 | B1 |
6391803 | Kim et al. | May 2002 | B1 |
6416822 | Chiang et al. | Jul 2002 | B1 |
6428859 | Chiang et al. | Aug 2002 | B1 |
6468924 | Lee et al. | Oct 2002 | B2 |
6482726 | Aminpur et al. | Nov 2002 | B1 |
6509601 | Lee et al. | Jan 2003 | B1 |
6528430 | Kwan et al. | Mar 2003 | B2 |
6551893 | Zheng et al. | Apr 2003 | B1 |
6569501 | Chiang et al. | May 2003 | B2 |
6576053 | Kim et al. | Jun 2003 | B1 |
6602784 | Sneh | Aug 2003 | B2 |
6632478 | Gaillard et al. | Oct 2003 | B2 |
6645574 | Lee et al. | Nov 2003 | B1 |
6689220 | Nguyen | Feb 2004 | B1 |
6723595 | Park | Apr 2004 | B2 |
6730614 | Lim et al. | May 2004 | B1 |
6743738 | Todd | Jun 2004 | B2 |
6756318 | Nguyen et al. | Jun 2004 | B2 |
6765303 | Krivokapic et al. | Jul 2004 | B1 |
6809421 | Hayasaka et al. | Oct 2004 | B1 |
6828218 | Kim et al. | Dec 2004 | B2 |
6835417 | Saenger et al. | Dec 2004 | B2 |
6861356 | Matsuse et al. | Mar 2005 | B2 |
6884466 | Kaloyeros et al. | Apr 2005 | B2 |
6930058 | Hill et al. | Aug 2005 | B2 |
6930060 | Chou et al. | Aug 2005 | B2 |
6943092 | Kim et al. | Sep 2005 | B2 |
6962876 | Ahn et al. | Nov 2005 | B2 |
6987240 | Jennings et al. | Jan 2006 | B2 |
7001844 | Chakravarti et al. | Feb 2006 | B2 |
7041335 | Chung | May 2006 | B2 |
7077904 | Cho et al. | Jul 2006 | B2 |
7081271 | Chung et al. | Jul 2006 | B2 |
7109129 | Papasouliotis | Sep 2006 | B1 |
7115166 | Vaartstra et al. | Oct 2006 | B2 |
7115528 | Vaartstra et al. | Oct 2006 | B2 |
7122222 | Xiao et al. | Oct 2006 | B2 |
7122464 | Vaartstra | Oct 2006 | B2 |
7125815 | Vaartstra | Oct 2006 | B2 |
7132353 | Xia et al. | Nov 2006 | B1 |
7141278 | Koh et al. | Nov 2006 | B2 |
7148155 | Tarafdar et al. | Dec 2006 | B1 |
7151039 | Lee et al. | Dec 2006 | B2 |
7172792 | Wang et al. | Feb 2007 | B2 |
7176084 | Lee et al. | Feb 2007 | B2 |
7205187 | Leith et al. | Apr 2007 | B2 |
7223649 | Oh et al. | May 2007 | B2 |
7235484 | Nguyen et al. | Jun 2007 | B2 |
7241686 | Marcadal et al. | Jul 2007 | B2 |
7244668 | Kim | Jul 2007 | B2 |
7250083 | Sneh | Jul 2007 | B2 |
7259050 | Chen et al. | Aug 2007 | B2 |
7261919 | Mehregany et al. | Aug 2007 | B2 |
7294582 | Haverkort et al. | Nov 2007 | B2 |
7297641 | Todd et al. | Nov 2007 | B2 |
7300885 | Hasebe et al. | Nov 2007 | B2 |
7314835 | Ishizaka et al. | Jan 2008 | B2 |
7341959 | Brcka | Mar 2008 | B2 |
7351668 | Chou et al. | Apr 2008 | B2 |
7361538 | Luan et al. | Apr 2008 | B2 |
7361611 | Chakravarti et al. | Apr 2008 | B2 |
7390743 | Shin | Jun 2008 | B2 |
7393561 | Paranjpe | Jul 2008 | B2 |
7399388 | Moghadam et al. | Jul 2008 | B2 |
7419888 | Yang et al. | Sep 2008 | B2 |
7435454 | Brcka | Oct 2008 | B2 |
7435684 | Lang et al. | Oct 2008 | B1 |
7462571 | Hasebe et al. | Dec 2008 | B2 |
7482247 | Papasouliotis et al. | Jan 2009 | B1 |
7488694 | Kim et al. | Feb 2009 | B2 |
7507676 | Chou et al. | Mar 2009 | B2 |
7510984 | Saito et al. | Mar 2009 | B2 |
7521331 | Park et al. | Apr 2009 | B2 |
7524762 | Marcadal et al. | Apr 2009 | B2 |
7544615 | Vaartstra | Jun 2009 | B2 |
7572052 | Ravi et al. | Aug 2009 | B2 |
7592231 | Cheng et al. | Sep 2009 | B2 |
7595010 | Chakravarti et al. | Sep 2009 | B2 |
7601648 | Chua et al. | Oct 2009 | B2 |
7615438 | Ahn et al. | Nov 2009 | B2 |
7615449 | Chung et al. | Nov 2009 | B2 |
7622369 | Lee et al. | Nov 2009 | B1 |
7622383 | Kim et al. | Nov 2009 | B2 |
7629267 | Wan et al. | Dec 2009 | B2 |
7632757 | Matsuura | Dec 2009 | B2 |
7633125 | Lu et al. | Dec 2009 | B2 |
7638170 | Li | Dec 2009 | B2 |
7645484 | Ishizaka | Jan 2010 | B2 |
7651729 | Kim et al. | Jan 2010 | B2 |
7651730 | Hasebe | Jan 2010 | B2 |
7651953 | Todd et al. | Jan 2010 | B2 |
7651959 | Fukazawa et al. | Jan 2010 | B2 |
7682657 | Sherman | Mar 2010 | B2 |
7687409 | Ahn et al. | Mar 2010 | B2 |
7713592 | Nguyen et al. | May 2010 | B2 |
7758920 | Hasebe et al. | Jul 2010 | B2 |
7776733 | Hasegawa | Aug 2010 | B2 |
7790633 | Tarafdar et al. | Sep 2010 | B1 |
7825039 | Takahashi et al. | Nov 2010 | B2 |
7906168 | Hasebe et al. | Mar 2011 | B2 |
7919416 | Lee et al. | Apr 2011 | B2 |
7923068 | Dickey et al. | Apr 2011 | B2 |
7923378 | Hasebe et al. | Apr 2011 | B2 |
7959985 | Ishizaka et al. | Jun 2011 | B2 |
7964241 | Hasebe et al. | Jun 2011 | B2 |
7964513 | Todd et al. | Jun 2011 | B2 |
7972980 | Lee et al. | Jul 2011 | B2 |
7981473 | Kim et al. | Jul 2011 | B2 |
7989365 | Park et al. | Aug 2011 | B2 |
8034673 | Kadonaga et al. | Oct 2011 | B2 |
8080290 | Hasebe et al. | Dec 2011 | B2 |
8101531 | Li et al. | Jan 2012 | B1 |
8119424 | Mather et al. | Feb 2012 | B2 |
8119544 | Hasebe et al. | Feb 2012 | B2 |
8133797 | van Schravendijk et al. | Mar 2012 | B2 |
8178448 | Nodera et al. | May 2012 | B2 |
8227032 | Dussarrat et al. | Jul 2012 | B2 |
8257789 | Matsunaga et al. | Sep 2012 | B2 |
8278224 | Mui et al. | Oct 2012 | B1 |
8334218 | Van Nooten et al. | Dec 2012 | B2 |
8357619 | Hasebe et al. | Jan 2013 | B2 |
8366953 | Kohno et al. | Feb 2013 | B2 |
8383525 | Raisanen et al. | Feb 2013 | B2 |
8394466 | Hong et al. | Mar 2013 | B2 |
8524612 | Li et al. | Sep 2013 | B2 |
8592328 | Hausmann et al. | Nov 2013 | B2 |
8633050 | Pierreux | Jan 2014 | B2 |
8637411 | Swaminathan et al. | Jan 2014 | B2 |
8647993 | Lavoie et al. | Feb 2014 | B2 |
8669185 | Onizawa et al. | Mar 2014 | B2 |
8728955 | LaVoie et al. | May 2014 | B2 |
8728956 | LaVoie et al. | May 2014 | B2 |
8956983 | Swaminathan et al. | Feb 2015 | B2 |
8999859 | Swaminathan et al. | Apr 2015 | B2 |
9076646 | Sims et al. | Jul 2015 | B2 |
9214334 | Swaminathan et al. | Dec 2015 | B2 |
9230800 | Lavoie et al. | Jan 2016 | B2 |
9257274 | Kang et al. | Feb 2016 | B2 |
9287113 | Kang et al. | Mar 2016 | B2 |
9355839 | Swaminathan et al. | May 2016 | B2 |
9355886 | Swaminathan et al. | May 2016 | B2 |
9373500 | Swaminathan et al. | Jun 2016 | B2 |
9502238 | Danek et al. | Nov 2016 | B2 |
9564312 | Henri et al. | Feb 2017 | B2 |
9570274 | Swaminathan et al. | Feb 2017 | B2 |
9570290 | Swaminathan et al. | Feb 2017 | B2 |
9611544 | Lavoie et al. | Apr 2017 | B2 |
9673041 | Swaminathan et al. | Jun 2017 | B2 |
9685320 | Kang et al. | Jun 2017 | B2 |
20020076507 | Chiang et al. | Jun 2002 | A1 |
20030008070 | Seutter et al. | Jan 2003 | A1 |
20030024477 | Okuda et al. | Feb 2003 | A1 |
20030143839 | Raaijmakers et al. | Jul 2003 | A1 |
20030200917 | Vaartstra | Oct 2003 | A1 |
20040033698 | Lee et al. | Feb 2004 | A1 |
20040043633 | Vaartstra | Mar 2004 | A1 |
20040053515 | Comita et al. | Mar 2004 | A1 |
20040121164 | Iacovangelo et al. | Jun 2004 | A1 |
20040129212 | Gadgil et al. | Jul 2004 | A1 |
20040219746 | Vaartstra et al. | Nov 2004 | A1 |
20040231799 | Lee et al. | Nov 2004 | A1 |
20050005851 | Keshner et al. | Jan 2005 | A1 |
20050042865 | Cabral et al. | Feb 2005 | A1 |
20050079661 | Cho et al. | Apr 2005 | A1 |
20050100670 | Dussarrat et al. | May 2005 | A1 |
20050109276 | Iyer et al. | May 2005 | A1 |
20050118837 | Todd et al. | Jun 2005 | A1 |
20050158983 | Hoshi et al. | Jul 2005 | A1 |
20050159017 | Kim et al. | Jul 2005 | A1 |
20050181535 | Yun et al. | Aug 2005 | A1 |
20050184397 | Gates et al. | Aug 2005 | A1 |
20050196977 | Saito et al. | Sep 2005 | A1 |
20050208718 | Lim et al. | Sep 2005 | A1 |
20050230047 | Collins et al. | Oct 2005 | A1 |
20050233553 | Kountz et al. | Oct 2005 | A1 |
20050260347 | Narwankar et al. | Nov 2005 | A1 |
20050276099 | Horng et al. | Dec 2005 | A1 |
20050287775 | Hasebe et al. | Dec 2005 | A1 |
20060009041 | Iyer et al. | Jan 2006 | A1 |
20060030148 | Seutter et al. | Feb 2006 | A1 |
20060084283 | Paranjpe et al. | Apr 2006 | A1 |
20060088985 | Haverkort et al. | Apr 2006 | A1 |
20060165890 | Kaushal et al. | Jul 2006 | A1 |
20060199357 | Wan et al. | Sep 2006 | A1 |
20060228868 | Ahn et al. | Oct 2006 | A1 |
20060286774 | Singh et al. | Dec 2006 | A1 |
20060286776 | Ranish et al. | Dec 2006 | A1 |
20060286818 | Wang et al. | Dec 2006 | A1 |
20070010071 | Matsuura | Jan 2007 | A1 |
20070026540 | Nooten et al. | Feb 2007 | A1 |
20070065576 | Singh et al. | Mar 2007 | A1 |
20070087574 | Gupta et al. | Apr 2007 | A1 |
20070087581 | Singh et al. | Apr 2007 | A1 |
20070116887 | Faguet | May 2007 | A1 |
20070134942 | Ahn et al. | Jun 2007 | A1 |
20070137572 | Matsuura et al. | Jun 2007 | A1 |
20070145483 | Ono | Jun 2007 | A1 |
20070167028 | Chou et al. | Jul 2007 | A1 |
20070215036 | Park et al. | Sep 2007 | A1 |
20070218701 | Shimizu et al. | Sep 2007 | A1 |
20070231487 | Ishizaka | Oct 2007 | A1 |
20070232082 | Balseanu et al. | Oct 2007 | A1 |
20070251444 | Gros-Jean et al. | Nov 2007 | A1 |
20070259110 | Mahajani et al. | Nov 2007 | A1 |
20080014759 | Chua et al. | Jan 2008 | A1 |
20080038936 | Todd et al. | Feb 2008 | A1 |
20080063791 | Hasebe et al. | Mar 2008 | A1 |
20080075881 | Won et al. | Mar 2008 | A1 |
20080081470 | Clark | Apr 2008 | A1 |
20080085610 | Wang et al. | Apr 2008 | A1 |
20080087890 | Ahn et al. | Apr 2008 | A1 |
20080123394 | Lee et al. | May 2008 | A1 |
20080131601 | Kim et al. | Jun 2008 | A1 |
20080138996 | Nishizuka | Jun 2008 | A1 |
20080139003 | Pirzada et al. | Jun 2008 | A1 |
20080207007 | Thridandam et al. | Aug 2008 | A1 |
20080213479 | Chou et al. | Sep 2008 | A1 |
20080242116 | Clark | Oct 2008 | A1 |
20080260969 | Dussarrat et al. | Oct 2008 | A1 |
20080274302 | Hasebe et al. | Nov 2008 | A1 |
20080311760 | Nodera et al. | Dec 2008 | A1 |
20080317972 | Hendriks et al. | Dec 2008 | A1 |
20090018668 | Galbraith | Jan 2009 | A1 |
20090039349 | Honda | Feb 2009 | A1 |
20090041952 | Yoon et al. | Feb 2009 | A1 |
20090065896 | Hwang et al. | Mar 2009 | A1 |
20090075490 | Dussarrat | Mar 2009 | A1 |
20090148625 | Yeom et al. | Jun 2009 | A1 |
20090155606 | Yoon et al. | Jun 2009 | A1 |
20090155968 | Min et al. | Jun 2009 | A1 |
20090163012 | Clark et al. | Jun 2009 | A1 |
20090191722 | Hasebe et al. | Jul 2009 | A1 |
20090203197 | Hanawa et al. | Aug 2009 | A1 |
20090208880 | Nemani et al. | Aug 2009 | A1 |
20090278224 | Kim et al. | Nov 2009 | A1 |
20100022099 | Van Nooten et al. | Jan 2010 | A1 |
20100025824 | Chen et al. | Feb 2010 | A1 |
20100048011 | Yeh et al. | Feb 2010 | A1 |
20100051578 | Chang et al. | Mar 2010 | A1 |
20100051579 | Kobayashi | Mar 2010 | A1 |
20100078316 | Edakawa et al. | Apr 2010 | A1 |
20100096688 | Balseanu et al. | Apr 2010 | A1 |
20100099236 | Kwon et al. | Apr 2010 | A1 |
20100099271 | Hausmann et al. | Apr 2010 | A1 |
20100102417 | Ganguli et al. | Apr 2010 | A1 |
20100120262 | Vorsa et al. | May 2010 | A1 |
20100124618 | Kobayashi et al. | May 2010 | A1 |
20100124621 | Kobayashi et al. | May 2010 | A1 |
20100126667 | Yin et al. | May 2010 | A1 |
20100136260 | Matsunaga et al. | Jun 2010 | A1 |
20100136313 | Shimizu et al. | Jun 2010 | A1 |
20100167555 | Maula et al. | Jul 2010 | A1 |
20100190353 | Nguyen et al. | Jul 2010 | A1 |
20100197129 | Ishikawa | Aug 2010 | A1 |
20100216268 | Katayama et al. | Aug 2010 | A1 |
20100221925 | Lee et al. | Sep 2010 | A1 |
20100255218 | Oka et al. | Oct 2010 | A1 |
20100304047 | Yang et al. | Dec 2010 | A1 |
20100304574 | Nodera et al. | Dec 2010 | A1 |
20100310791 | Shimazu et al. | Dec 2010 | A1 |
20110003445 | Murata et al. | Jan 2011 | A1 |
20110014795 | Lee et al. | Jan 2011 | A1 |
20110014796 | Hayashi | Jan 2011 | A1 |
20110014798 | Mallick et al. | Jan 2011 | A1 |
20110042744 | Cheng et al. | Feb 2011 | A1 |
20110064969 | Chen et al. | Mar 2011 | A1 |
20110086516 | Lee et al. | Apr 2011 | A1 |
20110124187 | Afzali-Ardakani et al. | May 2011 | A1 |
20110139176 | Cheung et al. | Jun 2011 | A1 |
20110143548 | Cheung et al. | Jun 2011 | A1 |
20110151142 | Seamons et al. | Jun 2011 | A1 |
20110151246 | Ramon Moreno et al. | Jun 2011 | A1 |
20110151674 | Tang et al. | Jun 2011 | A1 |
20110151678 | Ashtiani et al. | Jun 2011 | A1 |
20110159202 | Matsushita et al. | Jun 2011 | A1 |
20110176967 | Okuda et al. | Jul 2011 | A1 |
20110198756 | Thenappan et al. | Aug 2011 | A1 |
20110201210 | Sato et al. | Aug 2011 | A1 |
20110215445 | Yang et al. | Sep 2011 | A1 |
20110256726 | LaVoie et al. | Oct 2011 | A1 |
20110256734 | Hausmann et al. | Oct 2011 | A1 |
20110298099 | Lee et al. | Dec 2011 | A1 |
20110309475 | Lee | Dec 2011 | A1 |
20120009802 | LaVoie et al. | Jan 2012 | A1 |
20120009803 | Jung et al. | Jan 2012 | A1 |
20120021252 | Lee | Jan 2012 | A1 |
20120028454 | Swaminathan et al. | Feb 2012 | A1 |
20120028469 | Onizawa et al. | Feb 2012 | A1 |
20120058282 | Hong et al. | Mar 2012 | A1 |
20120077349 | Li et al. | Mar 2012 | A1 |
20120086048 | Park et al. | Apr 2012 | A1 |
20120108079 | Mahajani | May 2012 | A1 |
20120113672 | Dubrow et al. | May 2012 | A1 |
20120161405 | Mohn et al. | Jun 2012 | A1 |
20120164846 | Ha et al. | Jun 2012 | A1 |
20120193693 | Kanaya | Aug 2012 | A1 |
20120213940 | Mallick | Aug 2012 | A1 |
20120258261 | Reddy et al. | Oct 2012 | A1 |
20120280200 | Tada et al. | Nov 2012 | A1 |
20120282418 | Chou et al. | Nov 2012 | A1 |
20120315394 | Ito | Dec 2012 | A1 |
20130040447 | Swaminathan et al. | Feb 2013 | A1 |
20130058161 | Yamanaka et al. | Mar 2013 | A1 |
20130058162 | Yamanaka et al. | Mar 2013 | A1 |
20130071580 | Weidman et al. | Mar 2013 | A1 |
20130084688 | O'Meara et al. | Apr 2013 | A1 |
20130115783 | Kim et al. | May 2013 | A1 |
20130189854 | Hausmann et al. | Jul 2013 | A1 |
20130196516 | Lavoie et al. | Aug 2013 | A1 |
20130252437 | Sano et al. | Sep 2013 | A1 |
20130309415 | Swaminathan et al. | Nov 2013 | A1 |
20130319329 | Li et al. | Dec 2013 | A1 |
20130344248 | Clark | Dec 2013 | A1 |
20140030444 | Swaminathan et al. | Jan 2014 | A1 |
20140049162 | Thomas et al. | Feb 2014 | A1 |
20140051262 | Lavoie et al. | Feb 2014 | A9 |
20140087066 | Wang et al. | Mar 2014 | A1 |
20140094035 | Ji et al. | Apr 2014 | A1 |
20140106574 | Kang et al. | Apr 2014 | A1 |
20140113457 | Sims et al. | Apr 2014 | A1 |
20140120270 | Tour et al. | May 2014 | A1 |
20140120737 | Swaminathan et al. | May 2014 | A1 |
20140134827 | Swaminathan et al. | May 2014 | A1 |
20140141542 | Kang et al. | May 2014 | A1 |
20140141626 | Hausmann et al. | May 2014 | A1 |
20140170853 | Shamma et al. | Jun 2014 | A1 |
20140182619 | Goto et al. | Jul 2014 | A1 |
20140209562 | LaVoie et al. | Jul 2014 | A1 |
20140216337 | Swaminathan et al. | Aug 2014 | A1 |
20140239462 | Shamma et al. | Aug 2014 | A1 |
20140264555 | Ahn et al. | Sep 2014 | A1 |
20140273428 | Shero et al. | Sep 2014 | A1 |
20140273528 | Niskanen et al. | Sep 2014 | A1 |
20140295084 | Shirai et al. | Oct 2014 | A1 |
20140302686 | Pan et al. | Oct 2014 | A1 |
20150041867 | Han | Feb 2015 | A1 |
20150048740 | Valcore, Jr. et al. | Feb 2015 | A1 |
20150093902 | Huang et al. | Apr 2015 | A1 |
20150109814 | Chen et al. | Apr 2015 | A1 |
20150126042 | Pasquale et al. | May 2015 | A1 |
20150147483 | Fukazawa | May 2015 | A1 |
20150159271 | Lee et al. | Jun 2015 | A1 |
20150170900 | LaVoie | Jun 2015 | A1 |
20150206719 | Swaminathan et al. | Jul 2015 | A1 |
20150235835 | Swaminathan et al. | Aug 2015 | A1 |
20150243883 | Swaminathan et al. | Aug 2015 | A1 |
20150249013 | Arghavani et al. | Sep 2015 | A1 |
20150294905 | Wu et al. | Oct 2015 | A1 |
20160020092 | Kang et al. | Jan 2016 | A1 |
20160064211 | Swaminathan et al. | Mar 2016 | A1 |
20160148800 | Henri et al. | May 2016 | A1 |
20160148806 | Henri et al. | May 2016 | A1 |
20160155676 | Kang et al. | Jun 2016 | A1 |
20160163539 | Kang et al. | Jun 2016 | A9 |
20160163972 | Swaminathan et al. | Jun 2016 | A1 |
20160240428 | Tung et al. | Aug 2016 | A1 |
20160260584 | Marakhtanov et al. | Sep 2016 | A1 |
20160293385 | Kapoor et al. | Oct 2016 | A1 |
20160293398 | Danek et al. | Oct 2016 | A1 |
20160293838 | Swaminathan et al. | Oct 2016 | A1 |
20160322215 | Shaikh | Nov 2016 | A1 |
20160322371 | Yonemochi | Nov 2016 | A1 |
20160336178 | Swaminathan et al. | Nov 2016 | A1 |
20160365425 | Chen et al. | Dec 2016 | A1 |
20160379826 | Arghavani et al. | Dec 2016 | A9 |
20170092735 | Hashemi et al. | Mar 2017 | A1 |
20170103891 | Lee et al. | Apr 2017 | A1 |
20170110364 | Song et al. | Apr 2017 | A1 |
20170110533 | Huang et al. | Apr 2017 | A1 |
20170117134 | Henri et al. | Apr 2017 | A1 |
20170117150 | Liao et al. | Apr 2017 | A1 |
20170140926 | Pore et al. | May 2017 | A1 |
20170148628 | Swaminathan et al. | May 2017 | A1 |
Number | Date | Country |
---|---|---|
1732288 | Feb 2006 | CN |
1926668 | Mar 2007 | CN |
101006195 | Jul 2007 | CN |
101255548 | Sep 2008 | CN |
101378007 | Mar 2009 | CN |
101416293 | Apr 2009 | CN |
101535524 | Sep 2009 | CN |
101889331 | Nov 2010 | CN |
102906304 | Jan 2013 | CN |
103137864 | Jun 2013 | CN |
0 277 766 | Aug 1988 | EP |
0 541 212 | May 1993 | EP |
1 703 552 | Sep 2006 | EP |
2 278 046 | Jan 2011 | EP |
S48-043472 | Jun 1973 | JP |
H02-093071 | Apr 1990 | JP |
H06-177120 | Jun 1994 | JP |
10-98032 | Apr 1998 | JP |
H11-172439 | Jun 1999 | JP |
2001-274404 | Oct 2001 | JP |
2001-338922 | Dec 2001 | JP |
2002-9072 | Jan 2002 | JP |
2002-134497 | May 2002 | JP |
2002-164345 | Jun 2002 | JP |
2005-210076 | Aug 2005 | JP |
2005-310927 | Nov 2005 | JP |
2006-060091 | Mar 2006 | JP |
2007-165883 | Jun 2007 | JP |
2007-180362 | Jul 2007 | JP |
2007-287889 | Nov 2007 | JP |
2007-287890 | Nov 2007 | JP |
2008-500742 | Jan 2008 | JP |
2008-506262 | Feb 2008 | JP |
2008-109093 | May 2008 | JP |
2008-517479 | May 2008 | JP |
2008-258591 | Oct 2008 | JP |
4364320 | Aug 2009 | JP |
2009-540128 | Nov 2009 | JP |
2010-10497 | Jan 2010 | JP |
2010-043081 | Feb 2010 | JP |
2010-103484 | May 2010 | JP |
2010-118664 | May 2010 | JP |
2010-152136 | Jul 2010 | JP |
2010-245518 | Oct 2010 | JP |
2010-283388 | Dec 2010 | JP |
2011-023576 | Feb 2011 | JP |
2013166965 | Aug 2013 | JP |
2013225655 | Oct 2013 | JP |
2014-532304 | Dec 2014 | JP |
10-2001-0111448 | Dec 2001 | KR |
10-0356473 | Oct 2002 | KR |
10-2004-0001036 | Jan 2004 | KR |
10-2006-0056883 | May 2006 | KR |
10-0734748 | Jul 2007 | KR |
10-2009-0057665 | Jun 2009 | KR |
10-2009-0080019 | Jul 2009 | KR |
10-2009-0081396 | Jul 2009 | KR |
10-2009-0116433 | Nov 2009 | KR |
10-20130056608 | May 2013 | KR |
200701341 | Jan 2007 | TW |
201009942 | Mar 2010 | TW |
201042706 | Dec 2010 | TW |
201144475 | Dec 2011 | TW |
WO 2004032196 | Apr 2004 | WO |
WO 2006014471 | Feb 2006 | WO |
WO 2006018441 | Feb 2006 | WO |
WO 2006026350 | Mar 2006 | WO |
WO 2006104741 | Oct 2006 | WO |
WO 2007043709 | Apr 2007 | WO |
WO 2007118026 | Oct 2007 | WO |
WO 2011130326 | Oct 2011 | WO |
WO 2011130397 | Oct 2011 | WO |
WO 2012040317 | Mar 2012 | WO |
WO 2012048094 | Apr 2012 | WO |
WO 2012087737 | Jun 2012 | WO |
WO 2013032786 | Mar 2013 | WO |
WO 2013043330 | Mar 2013 | WO |
WO 2013065806 | May 2013 | WO |
WO 2013112727 | Aug 2013 | WO |
Entry |
---|
U.S. Appl. No. 15/201,221, filed Jul. 1, 2016, entitled “Selective Atomic Layer Deposition With Post-Dose Treatment.” |
U.S. Appl. No. 15/253,301, filed Aug. 31, 2016, entitled “Selective Atomic Layer Deposition for Gapfill Using Sacrificial Underlayer.” |
U.S. Appl. No. 15/199,608, filed Jun. 30, 2016, entitled “Apparatus and Method for Deposition and Etch in Gap Fill.” |
U.S. Office Action dated Jul. 1, 2016 issued in U.S. Appl. No. 13/963,212. |
U.S. Final Office Action dated Mar. 18, 2016 issued U.S. Appl. No. 14/607,997. |
U.S. Notice of Allowance dated Jun. 16, 2016 issued U.S. Appl. No. 14/607,997. |
U.S. Notice of Allowance dated Sep. 27, 2016 issued U.S. Appl. No. 14/607,997. |
U.S. Patent Board Decision on Appeal Before the Patent Trial and Appeal Board (Examiner Affirmed) dated Aug. 11, 2016 issued U.S. Appl. No. 13/224,240. |
U.S. Notice of Allowance dated Nov. 17, 2016 issued U.S. Appl. No. 13/224,240. |
U.S. Office Action dated Dec. 24, 2015 issued in U.S. Appl. No. 14/074,596. |
U.S. Notice of Allowance dated Feb. 12, 2016 issued in U.S. Appl. No. 14/074,596. |
U.S. Notice of Allowance dated Feb. 11, 2016 issued in U.S. Appl. No. 14/061,587. |
U.S. Notice of Allowance [Supplemental Notice of Allowability] dated Mar. 1, 2016 issued in U.S. Appl. No. 14/061,587. |
U.S. Final Office Action dated Nov. 1, 2016 issued in U.S. Appl. No. 14/194,549. |
U.S. Office Action dated Aug. 1, 2016 issued in U.S. Appl. No. 14/932,869. |
U.S. Notice of Allowance dated Feb. 25, 2016 issued in U.S. Appl. No. 14/187,145. |
U.S. Office Action dated Jun. 14, 2016 issued in U.S. Appl. No. 15/019,904. |
U.S. Notice of Allowance dated Oct. 13, 2016 issued in U.S. Appl. No. 15/019,904. |
U.S. Office Action dated Nov. 25, 2016 issued in U.S. Appl. No. 15/178,474. |
U.S. Final Office Action dated Aug. 24, 2016 issued in U.S. Appl. No. 14/335,785. |
U.S. Notice of Allowance dated Nov. 4, 2016 issued in U.S. Appl. No. 14/335,785. |
U.S. Office Action dated May 25, 2016 issued in U.S. Appl. No. 14/552,011. |
U.S. Notice of Allowance dated Sep. 26, 2016 issued in U.S. Appl. No. 14/552,011. |
U.S. Notice of Allowance dated Jul. 15, 2016 issued in U.S. Appl. No. 14/678,736. |
Taiwan Office Action dated Apr. 27, 2016 issued in Application No. TW 100113041. |
Chinese Second Office Action dated Feb. 2, 2016 issued in Application No. CN 201180045808.6. |
Taiwan Office Action dated May 5, 2016 issued in TW 100134208. |
Chinese First Office Action dated Nov. 19, 2015 issued in Application No. CN 201280046487.6. |
Chinese Second Office Action dated Aug. 22, 2016 issued in Application No. CN 201280046487.6. |
Japanese Office Action dated Aug. 23, 2016 issued in Application No. JP 2014-531838. |
Singapore Supplementary Examination Report dated Jun. 1, 2016 issued in SG 11201400633R. |
Taiwan Notice of Allowance and Search Report dated Dec. 18, 2015 issued in Application No. TW 101134692. |
Chinese First Office Action dated Nov. 6, 2015 issued in Application No. CN 201280053888.4. |
Chinese Second Office Action dated Aug. 16, 2016 issued in Application No. CN 201280053888.4. |
Taiwan Office Action and Search Report dated Jan. 27, 2016 issued in Application No. TW 101131556. |
Taiwan Office Action and Search Report dated Nov. 9, 2016 issued in Application No. TW 101131556. |
Chinese First Office Action dated May 19, 2016 issued in CN 201310021460.8. |
Chinese First Office Action dated Feb. 22, 2016 issued in Application No. CN 201380006994.1. |
Singapore Supplementary Examination Report dated Aug. 11, 2016 issued in SG 11201404315R. |
Taiwan Office Action and Search Report dated Jul. 20, 2016 issued in Application No. TW 102102879. |
Taiwan Office Action dated Oct. 25, 2016 issued in Application No. TW 102117772. |
Chinese First Office Action dated Apr. 11, 2016 issued in Application No. CN 201510086588.1. |
Japanese Office Action dated Apr. 19, 2016 issued in Application No. JP 201521804. |
Korean First Office Action dated Feb. 19, 2016, issued in Application No. KR 10-2015-0022610. |
Korean Final Office Action dated Jun. 29, 2016, issued in Application No. KR 10-2015-0022610. |
U.S. Appl. No. 14/932,869, filed Nov. 4, 2015, entitled “High Growth Rate Process for Conformal Aluminum Nitride.” |
U.S. Appl. No. 14/335,785, filed Jul. 18, 2014, entitled “Methods for Depositing Silicon Oxide.” |
U.S. Appl. No. 14/552,011, filed Nov. 24, 2014, entitled “Selective Inhibition in Atomic Layer Deposition of Silicon-Containing Films.” |
U.S. Appl. No. 14/678,736, filed Apr. 3, 2015, entitled “Deposition of Conformal Films by Atomic Layer Deposition and Atomic Layer Etch.” |
U.S. Office Action dated Mar. 15, 2013 issued in U.S. Appl. No. 13/084,399. |
U.S. Final Office Action dated Sep. 13, 2013 issued in U.S. Appl. No. 13/084,399. |
U.S. Notice of Allowance dated Jan. 15, 2014 issued in U.S. Appl. No. 13/084,399. |
U.S. Office Action dated Jan. 2, 2015 issued in U.S. Appl. No. 14/231,554. |
U.S. Final Office Action dated Jun. 10, 2015 issued in U.S. Appl. No. 14/231,554. |
U.S. Notice of Allowance dated Aug. 31, 2015 issued in U.S. Appl. No. 14/231,554. |
U.S. Office Action dated Sep. 14, 2012 issued in U.S. Appl. No. 13/084,305. |
U.S. Final Office Action dated Apr. 25, 2013 issued in U.S. Appl. No. 13/084,305. |
U.S. Office Action dated Apr. 13, 2011 issued in U.S. Appl. No. 12/889,132. |
U.S. Notice of Allowance dated Sep. 30, 2011 issued in U.S. Appl. No. 12/889,132. |
U.S. Office Action dated Aug. 1, 2012 issued in U.S. Appl. No. 13/011,569. |
U.S. Final Office Action dated Feb. 26, 2013 issued in U.S. Appl. No. 13/011,569. |
U.S. Notice of Allowance dated May 6, 2013 issued in U.S. Appl. No. 13/011,569. |
U.S. Office Action dated Apr. 4, 2013 issued U.S. Appl. No. 13/242,084. |
U.S. Notice of Allowance dated Jun. 19, 2013 issued U.S. Appl. No. 13/242,084. |
U.S. Notice of Allowance dated Sep. 19, 2013 issued U.S. Appl. No. 13/242,084. |
U.S. Office Action dated Sep. 21, 2015 issued U.S. Appl. No. 14/607,997. |
U.S. Notice of Allowance dated Aug. 7, 2014 issued U.S. Appl. No. 14/133,239. |
U.S. Notice of Allowance dated Nov. 26, 2014 issued U.S. Appl. No. 14/133,239. |
U.S. Office Action dated Apr. 29, 2013 issued U.S. Appl. No. 13/224,240. |
U.S. Final Office Action dated Nov. 22, 2013 issued U.S. Appl. No. 13/224,240. |
U.S. Examiner's Answer to Appeal Brief (filed May 22, 2014) Before the Patent Trial and Appeal Board dated Aug. 14, 2014 issued U.S. Appl. No. 13/224,240. |
U.S. Office Action dated Jun. 7, 2013 issued U.S. Appl. No. 13/414,619. |
U.S. Notice of Allowance dated Jul. 26, 2013, issued U.S. Appl. No. 13/414,619. |
U.S. Office Action dated May 24, 2013 issued U.S. Appl. No. 13/472,282. |
U.S. Notice of Allowance dated Oct. 4, 2013 issued U.S. Appl. No. 13/472,282. |
U.S. Office Action dated May 21, 2014 issued in U.S. Appl. No. 13/607,386. |
U.S. Notice of Allowance dated Oct. 8, 2014 issued in U.S. Appl. No. 13/607,386. |
U.S. Notice of Allowance dated Nov. 19, 2014 issued in U.S. Appl. No. 13/607,386. |
U.S. Office Action dated Jun. 13, 2014 issued in U.S. Appl. No. 13/953,616. |
U.S. Final Office Action dated Nov. 24, 2014 issued in U.S. Appl. No. 13/953,616. |
U.S. Office Action dated Dec. 11, 2014 issued in U.S. Appl. No. 14/074,596. |
U.S. Office Action dated May 15, 2015 issued in U.S. Appl. No. 14/074,617. |
U.S. Notice of Allowance dated Nov. 20, 2015 issued in U.S. Appl. No. 14/074,617. |
U.S. Office Action dated Aug. 14, 2015 issued in U.S. Appl. No. 14/061,587. |
U.S. Office Action dated Mar. 2, 2015 issued in U.S. Appl. No. 14/137,860. |
U.S. Notice of Allowance dated Oct. 1, 2015 issued in U.S. Appl. No. 14/137,860. |
U.S. Notice of Allowance [Supplemental Notice of Allowability] dated Oct. 22, 2015 issued in U.S. Appl. No. 14/137,860. |
U.S. Office Action dated Jul. 10, 2014 issued in U.S. Appl. No. 14/144,107. |
U.S. Final Office Action dated Jan. 15, 2015 issued in U.S. Appl. No. 14/144,107. |
U.S. Notice of Allowance dated Mar. 19, 2015 issued in U.S. Appl. No. 14/144,107. |
U.S. Office Action dated Oct. 21, 2015 issued in U.S. Appl. No. 14/194,549. |
U.S. Notice of Allowance dated Aug. 5, 2015 issued in U.S. Appl. No. 14/183,287. |
U.S. Office Action dated Jul. 2, 2015 issued in U.S. Appl. No. 14/187,145. |
U.S. Final Office Action dated Dec. 16, 2015 issued in U.S. Appl. No. 14/187,145. |
U.S. Office Action dated Apr. 13, 2015 issued in U.S. Appl. No. 14/335,785. |
U.S. Office Action dated Oct. 1, 2015 issued in U.S. Appl. No. 14/552,245. |
PCT International Search Report and Written Opinion, dated Oct. 20, 2011, issued in PCT/US2011/032186. |
PCT International Preliminary Report on Patentability, dated Oct. 26, 2012, issued in PCT/US2011/032186. |
PCT Invitation to Pay Additional Fees; Communication Re Partial International Search, dated Dec. 16, 2011, issued in PCT/US2011/032303. |
PCT International Search Report and Written Opinion, dated Feb. 20, 2012, issued in PCT/US2011/032303. |
PCT International Preliminary Report on Patentability and Written Opinion, dated Oct. 26, 2012, issued in PCT/US2011/032303. |
PCT International Search Report and Written Opinion dated May 2, 2012 issued in Application No. PCT/US2011/052537. |
PCT International Preliminary Report on Patentability and Written Opinion dated Apr. 4, 2013 issued in Application No. PCT/US2011/052537. |
Chinese First Office Action dated Jun. 2, 2015 issued in CN 201180045808.6. |
PCT International Search Report and Written Opinion dated Dec. 18, 2012, issued in Application No. PCT/US2012/052769. |
PCT International Preliminary Report on Patentability and Written Opinion dated Apr. 3, 2014, issued in Application No. PCT/US2012/052769. |
Chinese First Office Action [no translation] dated Nov. 19, 2015 issued in CN 201280046487.6. |
PCT International Search Report and Written Opinion dated Feb. 28, 2013, issued in Application No. PCT/US2012/051740. |
PCT International Preliminary Report on Patentability and Written Opinion dated Mar. 13, 2014, issued in Application No. PCT/US2012/051740. |
Chinese First Office Action [no translation] dated Nov. 6, 2015 issued in CN 201280053888.4. |
European Extended Search Report dated Apr. 14, 2014 issued in EP 13 15 2046. |
Korean Notice of Provisional Rejection dated Dec. 6, 2013 issued in KR 10-2012-0043797. |
Korean Final Office Action dated Aug. 18, 2014 issued in KR 10-2012-0043797. |
Korean Decision from the Patent Tribunal of the KIPO (description) dated May 26, 2015 issued in KR 10-2012-0043797. |
PCT International Search Report and Written Opinion dated May 27, 2013, issued in Application No. PCT/US2013/022977. |
PCT International Preliminary Report on Patentability and Written Opinion dated Aug. 7, 2014, issued in Application No. PCT/US2013/022977. |
Cecchi et al., (2007) “Ultra-thin conformal pore-sealing of low-k materials by plasma-assisted ALD,” University of New Mexico, Albuquerque, NM, Sandia National Labs, Albuquerque, NM, 1 page. |
Choi, Gyu-Jin et al., (2009) “Plasma-enhanced atomic layer deposition of TiO2 and AI-doped TiO2 films using N2O and O2 reactants,” Journal of the Electrochemical Society, 156(9):G138-G143. |
Hausmann et al. (2002) “Atomic Layer Deposition of Hafnium and Zirconium Oxides Using Metal Amide Precursors,” Chem. Mater. 14(10):4350-4358. |
Kim, H., et al., (2002) “The Growth of Tantalum Thin Films by Plasma-Enhanced Atomic Layer Deposition and Diffusion Barrier Properties,” Mat. Res. Soc. Symp. Proc. 716:B8.5.1-B8.5.6. |
King, Sean W., (Jul./Aug. 2011) “Plasma enhanced atomic layer deposition of SiNx:H and SiO2,” J. Vac. Sci. Technol. A29(4):041501-1 through 041501-9 (9 pages). |
Ko, Myoung-Gyun, et al., “Characterization of ruthenium thin film deposited by rf-direct plasma atomic layer deposition,” 209th ECS Meeting, Abstract #50, p. 1 [Downloaded on Jun. 9, 2014]. |
Ko, Myoung-Gyun, et al., (Oct. 2008) “Correlation of Carbon Content with the Thermal Stability of Ruthenium Deposited by Using RF-Direct Plasma-Enhanced Atomic-Layer Deposition,” Journal of the Korean Physical Society, 53(4):2123-2128. |
Lavareda et al., (2004) “Properties of a-Si:H TFTs using silicon carbonitride as dielectric,” Journal of Non-Crystalline Solids, 338-340:797-801. |
Lee et al., (2005) “Chemically conformal deposition of SrTiO3 thin films by Atomic Layer Deposition using conventional metal organic precursors and remote-plasma activated H2O,” School of Materials Science and Engineering, and Inter-university Semiconductor Research Center, Seoul National University, Microelectronic Engineering 80:158-161. |
Lee, Jong Ju, (2005) “Low-impurity, highly conformal atomic layer deposition of titanium nitride using NH3—Ar—H2 plasma treatment for capacitor electrodes,” Materials Letters, 59:615-617. |
Li, Xingcun, et al., (2011) “Atomic Layer Deposition A1203 Thin Films in Magnetized Radio Frequency Plasma Source,” Physics Procedia 18:100-106. |
Man P.F. et al., (Feb. 11-15, 1996) “Elimination of Post-Release Adhesion in Microstructures Using Conformal Fluorocarbon Coatings,” MEMS '96 Proceedings, IEEE, pp. 55-60. |
Nguyen, S.V. et al., (Jan./Mar. 1999) “Plasma-assist chemical vapor deposition of dielectric thin films for ULSI semiconductor circuits,” IBM J.Res.Develop. 43(1.2):5-38. |
Plasma Enhanced Atomic Layer Deposition (PEALD), Website: http://www.asm.com/index.php?option=com—content&task=view&id=19&Itemid=161 (2010), 1 page. |
“PlasmaPro™ NGP® 80 Range,” Oxford Instruments (2010), 8 pages. |
Puurunen, Riikka L. (2005) “Surface chemistry of atomic layer deposition: A case study for the trimethylaluminum/water process,” Journal of Applied Physics, 97:121301-1-121301-52. |
Van der Straten et al. (2004) “Atomic layer deposition of tantalum nitride for ultrathin liner applications in advanced copper metallization schemes,” Journal of Materials Research, 19(2):447-453. |
U.S. Office Action dated Jan. 12, 2017 issued in U.S. Appl. No. 13/963,212. |
U.S. Notice of Allowance (Supplemental Notice of Allowability) dated Feb. 21, 2017 issued U.S. Appl. No. 13/224,240. |
U.S. Office Action dated Dec. 30, 2016 issued in U.S. Appl. No. 15/015,952. |
U.S. Office Action dated Apr. 19, 2017 issued in U.S. Appl. No. 14/194,549. |
U.S. Notice of Allowance dated Feb. 10, 2017 issued in U.S. Appl. No. 15/178,474. |
U.S. Notice of Allowance dated Mar. 27, 2017 issued in U.S. Appl. No. 15/178,474. |
U.S. Notice of Allowance dated Apr. 18, 2017 issued in U.S. Appl. No. 15/178,474. |
U.S. Notice of Allowance dated Feb. 22, 2017 issued in U.S. Appl. No. 14/335,785. |
U.S. Notice of Allowance dated Mar. 21, 2017 issued in U.S. Appl. No. 14/335,785. |
U.S. Notice of Allowance [Corrected Notice of Allowability] dated Apr. 19, 2017 issued in U.S. Appl. No. 14/335,785. |
Korean Office Action, dated Feb. 7, 2017, issued in Application No. KR 2012-7004925. |
Japanese Office Action dated Jan. 10, 2017 issued in JP 2013-007612. |
Taiwan Examination Report dated Mar. 29, 2017 issued in TW 102102054. |
Chinese Second Office Action dated Feb. 6, 2017 issued in Application No. CN 201380006994.1. |
Japanese Notification of Reasons for Rejection dated Jan. 10, 2017 issued in JP2014-554825. |
Taiwan Examination Report dated Jan. 11, 2017 issued in Application No. TW 102138326. |
U.S. Appl. No. 15/426,889, filed Feb. 7, 2017, Swaminathan et al. |
U.S. Appl. No. 15/399,637, filed Jan. 5, 2017, Henri et al. |
U.S. Appl. No. 15/201,221, filed Jul. 1, 2016, Kumar et al. |
U.S. Appl. No. 15/253,301, filed Aug. 31, 2016, Ou et al. |
U.S. Appl. No. 15/199,608, filed Jun. 30, 2016, Singhal. |
U.S. Final Office Action dated Jun. 28, 2017 issued in U.S. Appl. No. 13/963,212. |
U.S. Notice of Allowance dated Jun. 15, 2017 issued in U.S. Appl. No. 15/015,952. |
U.S. Office Action dated Jun. 9, 2017 issued in U.S. Appl. No. 15/224,347. |
Korean Office Action, dated May 23, 2017, issued in Application No. KR 10-2013-7010291. |
Chinese Second Office Action dated Apr. 13, 2017 issued in CN 201310021460.8. |
Chinese First Office Action dated Nov. 28, 2016 issued in Application No. CN 201410521390.7. |
Chinese First Office Action dated May 27, 2017 issued in Application No. CN 201510091775.9. |
Chinese Second Office Action dated Mar. 20, 2017 issued in Application No. CN 201510086588.1. |
U.S. Appl. No. 15/609,864, filed May 31, 2017, Swaminathan et al. |
U.S. Appl. No. 15/654,186, filed Jul. 19, 2017, Kang et al. |
U.S. Notice of Allowance dated Jun. 27, 2017 issued in U.S. Appl. No. 15/199,608. |
Number | Date | Country | |
---|---|---|---|
20160118246 A1 | Apr 2016 | US |
Number | Date | Country | |
---|---|---|---|
61884923 | Sep 2013 | US | |
61324710 | Apr 2010 | US | |
61372367 | Aug 2010 | US | |
61379081 | Sep 2010 | US | |
61417807 | Nov 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14137860 | Dec 2013 | US |
Child | 14987542 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13084399 | Apr 2011 | US |
Child | 14137860 | US |